Drug Therapy in Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|18|2205-2217

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.18, 2004-07, pp. : 2205-2217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy-resistant schizophrenia: a psychopharmacotherapeutic approach with an atypical antipsychotic drug (clozapine)

By Giannelli A.   Volonteacute M.V.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 340-340

Elsevier

Access to resources Recommend Favorite

Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues

By Lindström E.  

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 105-124

Adis International

Access to resources Recommend Favorite

Pharmacogenetics as a tool in the therapy of schizophrenia

By Wilffert Bob   Zaal Rianne   Brouwers Jacobus  

Pharmacy World and Science, Vol. 27, Iss. 1, 2005-02 ,pp. : 20-30

Springer Publishing Company

Access to resources Recommend Favorite

Drug treatment of the negative symptoms of schizophrenia

By King D.J.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

Cognitive Therapy for Schizophrenia: Treatment and Dissemination

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2269-2275

Bentham Science Publishers

Access to resources Recommend Favorite